Note: Ingredients listed on restricted chemical lists
EC/CAS
203-726-8/109-99-9
Name of the chemical
Tetrahydrofuran (618/2012)
Concentration
N/A
General Information
Version
1.0
Revision date
2023-12-22
Product name
TETRAHYDROFURAN EXTRA PURE
Substance name
TETRAHYDROFURAN EXTRA PURE
Product Synonyms
Oxolane, 1,4-Butylene oxide, Tetra-methylene oxide, THF
CAS No.
109-99-9
Emergency telephone
91 22 6663 6663
Icons in SDS
Company Information
company name
LOBA CHEMIE PVT. LTD
e-mail address of the competent person responsible for the Safety Data Sheet
info@lobachemie.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H302, H319, H335, H351
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Highly flammable liquid and vapour. Suspected of causing cancer. Harmful if swallowed. May cause respiratory irritation. Causes serious eye irritation.
2.2 Label elements
Labelling
Hazard pictograms
GHS02 GHS07 GHS08
Signal word
Danger
Hazard statements
H225 - Highly flammable liquid and vapour. H302 - Harmful if swallowed. H319 - Causes serious eye irritation. H335 - May cause respiratory irritation. H351 - Suspected of causing cancer.
Precautionary statements
P202 - Do not handle until all safety precautions have been read and understood. P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P233 - Keep container tightly closed. P301+P312 - IF SWALLOWED: Call a POISON CENTRE or doctor if you feel unwell. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Supplemental label elements
EUH019 - May form explosive peroxides. Nordic countries regulation Denmark MAL code : 00-3 (Executive Order No. 301 from 1993)
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII